Introduction
============

*Lactococcus lactis cremoris*is commonly considered to be a non-pathogenic organism in humans. It is recognized as a commensal organism of mucocutaneous surfaces, however, over the past 50 years, there have been a number of case reports \[[@B1]-[@B11]\] demonstrating the potential for this organism to cause infection. We report the first case of cholangitis associated with septicaemia caused by *Lactococcus lactis cremoris*.

Case presentation
=================

A 72-year-old lady, normally fit and well, presented with a 5-day history of jaundice and abdominal pain. She was nauseated and had dark urine. On initial assessment, she was deeply icteric and her temperature was 38.2°C but she was haemodynamically stable. Systemic examination did not reveal any other abnormalities, specifically there were no stigmata of chronic liver disease. No organs or lymph nodes were palpable and the abdomen was soft and non-tender.

Biochemical analyses demonstrated a leukocytosis and neutrophilia; haemoglobin (Hb) 11.9 g/dL, white blood cell count (WCC) 13.9 × 10^9^/L, neutrophils 11.4 × 10^9^/L. An acute phase response was evident with C-reactive protein (CRP) 131 mg/L. A mixed cholestatic and hepatic picture of hepatic enzymes with alkaline phosphatase (ALP) 340 U/L, alanine aminotransferase (ALT) 240 U/L and gamma-glutamyl-transferase (γGT) 381 U/L was demonstrated; total bilirubin was 351 μmol/L. Hepatic synthetic function was preserved with albumin 30 g/L and prothrombin time (PT) of 13.8 seconds. A clinical diagnosis of cholangitis was made on the basis of Charcot\'s triad (abdominal pain, fever and jaundice), and empirical antibiotic therapy (oral ciprofloxacin 500 mg bd) was commenced.

An ultrasound of the biliary tree was performed demonstrating dilatation of the common bile duct to 1.5 cm with visualization of at least one stone in the lumen of the duct. Intrahepatic duct dilatation was also noted. Blood cultures confirmed a *Lactococcus lactis cremoris*septicaemia. The organism was sensitive to tazobactam/piperacillin and co-amoxiclav. In light of these results, antibiotic therapy was changed to intravenous tazobactam/piperacillin 4.5 g tds.

The patient proceeded to endoscopic retrograde cholangiopancreatogram (ERCP) where an impacted common bile duct stone was identified. Unfortunately, this was not amenable to endoscopic removal despite sphincterotomy; however two biliary stents were inserted with good drainage.

The patient recovered rapidly with resolution of her symptoms and signs and was discharged home 48 hours post-ERCP. Treatment was completed with 2 weeks of oral co-amoxiclav 625 mg tds.

Discussion
==========

The Tokyo Consensus guidelines of 2007 have now established definitive diagnostic criteria and severity assessment of cholangitis \[[@B12]\]. The diagnosis of cholangitis is made either by the presence of Charcot\'s triad or by the presence of two of these features backed up by abnormal liver function tests, raised inflammatory markers and imaging demonstrating a dilated biliary tree. Severity is assessed by the presence or absence of organ failure once a diagnosis has been made and response to initial therapy. As our patient had no signs of organ failure but failed to respond to the primary treatment, she constitutes cholangitis of moderate severity.

Empirical antibiotic therapy for cholangitis is targeted towards gut organisms, particularly Gram-negative organisms. Commonly (including in our unit), ciprofloxacin is considered to be an appropriate empirical therapy. This is backed up by reports of an 85% clinical cure rate in trials \[[@B13]\]. The Tokyo Consensus group \[[@B13]\] failed to recommend a single specific empirical treatment, therefore local antibiotic guidelines will continue to direct empirical therapy. In the presence of positive microbiological investigations, there is a clear consensus that agents should be changed for more appropriate treatment according to sensitivity.

Biliary drainage reduces mortality and speeds recovery from cholangitis and is therefore a vital part of management \[[@B14]\]. The Tokyo guidelines recognize that this must be done in an emergency setting for patients with severe cholangitis and as promptly as practical in other patients. Endoscopic drainage is the preferred modality \[[@B15]\].

*Lactococcus lactis cremoris*is a Gram-positive coccus, formerly classified as *Streptococcus cremoris*but now recognized as a member of the genus *Lactococcus*\[[@B3]\]. This species is commonly regarded as non-pathogenic in immunocompetent adults, however we report the thirteenth case to our knowledge of this pathogen causing clinically significant infection. Previously, four cases of bacterial endocarditis \[[@B4],[@B6],[@B9],[@B11]\], one of septicaemia \[[@B7]\], two liver abscesses \[[@B3],[@B5]\] and one each of necrotizing pneumonitis \[[@B10]\], septic arthritis \[[@B8]\], deep neck infection \[[@B2]\], cerebellar abscess \[[@B4]\] and canaliculitis \[[@B1]\] have been reported. Of these, it appears that nine were immunocompetent patients. All bar one of the case reports were in adults (Table [1](#T1){ref-type="table"}).

###### 

Previously reported cases of *Lactococcus lactis cremoris*associated infections

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year              Age   Sex   Site of infection                     Exposure to unpasteurized milk products       Treatment                                                 Outcome                                                       Immune status
  ----------------- ----- ----- ------------------------------------- --------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------- -------------------------------
  2006 \[[@B1]\]    80    F     Canaliculitis                         None                                          Oral ampicillin and topical chloramphenicol               Complete resolution                                           Normal

  2005 \[[@B2]\]    68    M     Deep neck infection                   Cow breeder and consumed unpasteurized milk   Ceftriaxone and metronidazole for 6 weeks                 Resolution on discharge                                       Previous malignancy

  2004 \[[@B3]\]    79    F     Liver abscess                         None                                          Percutaneous drainage, Imipenem Cilastatin for 5 weeks    Complete resolution                                           Normal

  2002 \[[@B4]\]    45    F     Cerebellar abscess                    Not commented                                 Ceftriaxone 8 weeks, gentamicin 2 weeks, Metronidazole    No residual deficit and no recurrence at 9 months             Normal

  2002 \[[@B3]\]    67    M     Endocarditis                          History of drinking unpasteurized milk        Co-amoxiclav and gentamicin 15 days                       Well 6 months post discharge                                  Normal

                                                                                                                    Penicillin for 6 weeks                                                                                                  

  2000 \[[@B5]\]    14    F     Liver abscess                         None                                          Percutaneous drainage                                     Discharged from hospital on day 48                            Normal

                                                                                                                    Cefotiam, Amikacin and Clindamycin for 8 days                                                                           

                                                                                                                    Panipenem for 8 days                                                                                                    

                                                                                                                    Piperacillin 15 days and amikacin 10 days                                                                               

  1996 \[[@B6]\]    56    M     Endocarditis                          None                                          Penicillin G for 12 days and Clarithromycin for 18 days   Well 18 months post discharge                                 Normal

  1995 \[[@B7]\]    69    M     Septicaemia                           Yoghurt ingested                              Cefotaxime and Amikacin                                   No comment                                                    Chronic lymphocytic leukaemia

  1993 \[[@B8]\]    57    F     Septic arthritis                      Unpasteurized milk                            Penicillin for 6 weeks                                    Deformity 8 months post discharge, but no ongoing infection   Normal

  1990 \[[@B9]\]    65    F     Endocarditis                          Not commented                                 Benzylpenicillin and gentamicin                           No ongoing infection                                          Normal

  1990 \[[@B10]\]   24    M     Necrotizing pneumonitis and empyema   Unpasteurized milk and cheese eaten           Thoracocentesis (\*3)\                                    Well 1 month post discharge                                   HIV positive
                                                                                                                    Penicillin and clindamycin 15 days                                                                                      

  1955 \[[@B11]\]   21    M     Endocarditis                          Sour cream known to contain *S. Lactis*       Penicillin and Dihydrostreptomycin for 22 days            Well 4 months post discharge                                  Normal
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Lactococcus lactis cremoris*is a recognized skin commensal of cattle and is also used in the dairy industry for milk fermentation. It may therefore be present in unpasteurized dairy products. Of the previously reported cases, six have been associated with a clear history of exposure to unpasteurized dairy products; in one of these cases, the organism was isolated from the milk product (Table [1](#T1){ref-type="table"}). Our patient is not aware of having had any such exposure.

Conclusion
==========

This report provides corroboration of evidence that *Lactococcus lactis cremoris*is a potential pathogen in immunocompetent adults. *Lactococcus lactis cremoris*has now been reported as a pathogen in many different systems, both acutely and subacutely. This may well represent an underreporting of the true incidence of invasive infection related to this organism.

Diagnosis and assessment of the clinical severity of cholangitis are now the subject of consensus guidelines. These guidelines also extend to the appropriate timing and method of biliary drainage. However, there remains a debate about the most appropriate empirical antibiotic therapy in this condition. In the light of this case, it is important to consider other potential pathogens causing ascending cholangitis.
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